AIVRT Published Articles

Hou, Y., Zarodkiewicz, P., Cortázar, J.T., Stoner, D., Tulauskas, Z., Macori, G., Valvano, M.A., Ingram, R. and McClean, S., 2025. Protective efficacy of two novel Klebsiella pneumoniae vaccine antigens, LysM/BON and OMPP1, in a murine model. Vaccine, 66, p.127844.

Lapeyre, R., Rezk, N., McClean, S., & Moore, A. C. (2025). Systematic mapping review of preclinical and clinical studies of Staphylococcus aureus vaccines. Vaccine, 61, 127333.

Rezk, N., & McClean, S. (2025). Harnessing the Potential of mRNA Vaccines Against Infectious Diseases. Microbial Biotechnology, 18(8), e70212.

Jurado-Martín, I., Tomás-Cortázar, J., Hou, Y., Sainz-Mejías, M., Mysior, M.M., Sadonès, O., Huebner, J., Romero-Saavedra, F., Simpson, J.C., Baugh, J.A. and McClean, S., 2024. Proteomic approach to identify host cell attachment proteins provides protective Pseudomonas aeruginosa vaccine antigen FtsZ. npj Vaccines, 9(1), p.204.

Jurado-Martín, I., Tomás-Cortázar, J., Rezk, N., Hou, Y., Saínz-Mejías, M., Bruce, R., Startseva, M., Ma, C. and McClean, S., 2025. The novel antigen, lipopolysaccharide export protein LptH, protects mice against Pseudomonas aeruginosa acute pneumonia in monovalent and multivalent vaccines. Vaccine, 56, p.127145.

Sainz-Mejías, M., Ma, C., Hou, Y., Jurado-Martin, I., Romerio, A., Franco, A.R., Shaik, M.M., Tomás-Cortázar, J., Peri, F. and McClean, S., 2025. Monosaccharide-Based Synthetic TLR4 Agonist Enhances Vaccine Efficacy against Pseudomonas aeruginosa Challenge. ACS Infectious Diseases, 11(4), pp.894-904.

Tomás-Cortázar, J., Quinn, C., Corcoran, N., Blanco, A., Christensen, D. and McClean, S., 2024. BpOmpW antigen administered with CAF01 adjuvant stimulates comparable T cell responses to Sigma adjuvant system. Vaccine: X, 17, p.100438.